Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapy

Published:2014-02-28 Issue:3 Volume:21 Page:110-114
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

An S J,Huang Y S,Chen Z H,Han J F,Yang J J,Zhou Q,Xie Z,Yang Y,Yan H H,Wu Y L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt20145.pdf

Reference20 articles.

1. Hanrahan EO, Lin HY, Kim ES, Yan S, Du DZ, McKee KS et al. Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2010; 28: 193–201.

2. Crinò L, Dansin E, Garrido P, Griesinger F, Laskin J, Pavlakis N et al. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study. Lancet Oncol 2010; 11: 733–740.

3. An SJ, Huang YS, Chen ZH, Su J, Yang Y, Chen JG et al. Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy. Med Oncol 2012; 29: 627–632.

4. Zhao YY, Xue C, Jiang W, Zhao HY, Huang Y, Feenstra K et al. Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab. J Thorac Oncol 2012; 7: 71–75.

5. Aggarwal C, Somaiah N, Simon G . Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed? Cancer Biol Ther 2012; 13: 247–263.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic features of lung cancer patients in Indonesia’s national cancer center;BMC Pulmonary Medicine;2024-01-20

2. A bifunctional agent for efficient imaging of PD-L1 and antimelanoma activity;Bioorganic Chemistry;2023-12

3. Gene Cluster Expression Index (GCEI) and Potential Indications for Targeted Therapy and Immunotherapy;2023-06-19

4. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice;Marine Drugs;2021-03-29

5. Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings;BMC Cancer;2021-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3